16 results
8-K
ARCT
Arcturus Therapeutics Holdings Inc
13 Dec 22
Arcturus Appoints John Markels, Ph.D. to its Board of Directors
4:14pm
as filed with the Securities and Exchange Commission on May 12, 2022.
John H. Markels, Ph.D., age 56, has over 35 years of leadership experience … , Managing Director, Mexico from November 2013 to January 2017. Prior to his commercial roles, he had a long career in senior leadership positions
8-K
EX-99.1
ARCT
Arcturus Therapeutics Holdings Inc
13 Dec 22
Arcturus Appoints John Markels, Ph.D. to its Board of Directors
4:14pm
. Markels has over 35 years of leadership experience in the pharmaceutical industry at Merck & Co., Inc., with a deep background in manufacturing … leadership positions in major regions worldwide in manufacturing technology, operations, supply chain and strategy. Dr. Markels has worked in every region
DEFR14A
7wwd00sjkoqtas 7sy
12 May 22
Revised proxy
5:00pm
8-K
EX-99.1
8tl7o d6cnyzt6
13 Dec 21
Arcturus Therapeutics Appoints Jing Marantz, M.D., Ph.D., M.B.A. to its Board of Directors
5:17pm
8-K
EX-99.1
6ibsjfymbd v2
7 Nov 19
Arcturus Therapeutics Announces Third Quarter Financial Results and Provides Corporate Update
4:53pm
DEF 14A
76hh3r2xz76xeh o1u
1 Oct 19
Definitive proxy
6:07am
8-K12B
u1kzmcvuj0ssp
14 Jun 19
Notification of registration of securities
5:10pm
424B3
bo8n7u
12 Apr 19
Prospectus supplement
4:39pm
S-4/A
6pcirz
11 Apr 19
Registration of securities issued in business combination transactions (amended)
5:26pm
S-4
hsi 1izzisd
15 Mar 19
Registration of securities issued in business combination transactions
9:35pm
- Prev
- 1
- Next